Approvals/CIMA-AEMPS/DEFERASIROX AUROVITAS 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

DEFERASIROX AUROVITAS 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 5e7885c4de55f235
Drug Cima Aemps Name: DEFERASIROX AUROVITAS 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86260
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2021-10-05
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 360 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Aurovitas Spain, S.A.U.

DEFERASIROX

360 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 5, 2021

Approval ID

5e7885c4de55f235

Type

Standard